Treatment of hepatic diseases using fk 506 and related...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/229, 167/233

A61K 31/455 (2006.01) A61K 31/335 (2006.01) A61K 31/395 (2006.01) A61K 31/40 (2006.01) A61K 31/445 (2006.01) C07D 498/18 (2006.01)

Patent

CA 2012978

The disclosure describes the administration of macrolide compounds having the structure: (see formula I) wherein R1 is hydroxy or protected hydroxy, R2 is hydrogen, hydroxy or protected hydroxy, R3 is methyl, ethyl, propyl or a11y1, R4 is hydroxy, methoxy or oxo (=O), n is an integer of 1 or 2 and the symbol of a line and a dotted line is a single bond or a double bond, provided that R2 is not protected hydroxy when R4 is hydroxy or oxo, and salts thereof, for regener- ating mammal liver tissue, stimulating hypertrophy and hyperplasia of hepatocytes and treating hepatic disease.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of hepatic diseases using fk 506 and related... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of hepatic diseases using fk 506 and related..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of hepatic diseases using fk 506 and related... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1710198

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.